(Q57636866)
Statements
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study (English)
J Thaler
W Hilbe
U Apfelbeck
W Linkesch
H Seewann
J Pont
M Bernhart
M Stöger
H Niessner
K Abbrederis
D Geissler
H Hausmaninger
W Lin
H Ludwig
A Lang
C Duba
T Fluckinger
R Greil
K Grünewald
G Konwalinka